Weaponized Mycoplasma – What Doesn’t Kill You, Will Permanently Disable You
(Whale) Weaponized mycoplasma is a bioweapon designed to achieve a soft kill of the population on a massive scale. Big Pharma was instrumental in this research along with the military bioweapons R&D agencies in increasing the efficacy, transmission and contagion factors of this bioweapon.
This disease agent is not a bacteria and not a virus; it is a mutated form of the brucellosis bacteria, mutated with a visna virus, from which the mycoplasma, is extracted. Research from Dr. Shyh-Ching Lo also names the mycoplasma as a cause of cancer. The U.S. Public Health Service also closely followed the progress of biological warfare research and development from the very start of the program, and the Centers for Disease Control (CDC), and the National Institutes of Health (NIH) in the United States were working with the military in weaponizing these diseases.
Dr. Garth Nicolson – Weaponized Mycoplasmas
The following is an article from 2001 about pathogenic Mycoplasma and biological warfare which is highly revealing, to say the least…
(Donald W. Scott MA, MSc.| Nexus Magazine) Several strains of mycoplasma have been “engineered” to become more dangerous. They are now being blamed for AIDS, cancer, CFS, MS, CJD and other neurosystemic diseases.
I – PATHOGENIC MYCOPLASMA
A Common Disease Agent Weaponised
There are 200 species of Mycoplasma. Most are innocuous and do no harm; only four or five are pathogenic. Mycoplasma fermentans (incognitus strain) probably comes from the nucleus of the Brucella bacterium. This disease agent is not a bacterium and not a virus; it is a mutated form of the Brucella bacterium, combined with a visna virus, from which the mycoplasma is extracted.
The pathogenic Mycoplasma used to be very innocuous, but biological warfare research conducted between 1942 and the present time has resulted in the creation of more deadly and infectious forms of Mycoplasma. Researchers extracted this mycoplasma from the Brucella bacterium and actually reduced the disease to a crystalline form. They “weaponized” it and tested it on an unsuspecting public in North America.
Dr. Maurice Hilleman, the chief virologist for the pharmaceutical company Merck Sharp & Dohme, stated that this disease agent is now carried by everybody in North America and possibly most people throughout the world.
Despite reporting flaws, there has clearly been an increased incidence of all the neuro/systemic degenerative diseases since World War II and especially since the 1970s with the arrival of previously unheard-of diseases like chronic fatigue syndrome and AIDS.
According to Dr Shyh-Ching Lo, senior researcher at The Armed Forces Institute of Pathology and one of America’s top mycoplasma researchers, this disease agent causes many illnesses including AIDS, cancer, chronic fatigue syndrome, Crohn’s colitis, Type I diabetes, multiple sclerosis, Parkinson’s disease, Wegener’s disease and collagen-vascular diseases such as rheumatoid arthritis and Alzheimer’s.
Dr Charles Engel, who is with the US National Institutes of Health, Bethesda, Maryland, stated the following at an NIH meeting on February 7, 2000: “I am now of the view that the probable cause of chronic fatigue syndrome and fibromyalgia is the mycoplasma…”
I have all the official documents to prove that mycoplasma is the disease agent in chronic fatigue syndrome/fibromyalgia as well as in AIDS, multiple sclerosis and many other illnesses. Of these, 80% are US or Canadian official government documents, and 20% are articles from peer-reviewed journals such as the Journal of the American Medical Association, New England Journal of Medicine and the Canadian Medical Association Journal. The journal articles and government documents complement each other.
How the Mycoplasma Works
The mycoplasma acts by entering into the individual cells of the body, depending upon your genetic predisposition.
You may develop neurological diseases if the pathogen destroys certain cells in your brain, or you may develop Crohn’s colitis if the pathogen invades and destroys cells in the lower bowel.
Once the mycoplasma gets into the cell, it can lie there doing nothing sometimes for 10, 20 or 30 years, but if a trauma occurs like an accident or a vaccination that doesn’t take, the mycoplasma can become triggered.
Because it is only the DNA particle of the bacterium, it doesn’t have any organelles to process its own nutrients, so it grows by uptaking pre-formed sterols from its host cell and it literally kills the cell; the cell ruptures and what is left gets dumped into the bloodstream.
II- CREATION OF THE MYCOPLASMA
A Laboratory-Made Disease Agent
Many doctors don’t know about this mycoplasma disease agent because it was developed by the US military in biological warfare experimentation and it was not made public. This pathogen was patented by the United States military and Dr. Shyh-Ching Lo. I have a copy of the documented patent from the US Patent Office. (1)
All the countries at war were experimenting with biological weapons. In 1942, the governments of the United States, Canada, and Britain entered into a secret agreement to create two types of biological weapons (one that would kill, and one that was disabling) for use in the war against Germany and Japan, who were also developing biological weapons. While they researched a number or disease pathogens, they primarily focused on the Brucella bacterium and began to weaponize it.
From its inception, the biowarfare program was characterized by continuing in-depth review and participation by the most eminent scientists, medical consultants, industrial experts, and government officials, and it was classified Top Secret.
The US Public Health Service also closely followed the progress of biological warfare research and development from the very start of the program, and the Centers for Disease Control (CDC) and the National Institutes of Health (NIH) in the United States were working with the military in weaponizing these diseases. These are diseases that have existed for thousands of years, but they have been weaponized – which means they’ve been made more contagious and more effective. And they are spreading.
The Special Virus Cancer Program, created by the CIA and NIH to develop a deadly pathogen for which humanity had no natural immunity (AIDS), was disguised as a war on cancer but was actually part of MKNAOMI.2 Many members of the Senate and House of Representatives do not know what has been going on. For example, the US Senate Committee on Government Reform had searched the archives in Washington and other places for the document titled “The Special Virus Cancer Program: Progress Report No. 8”, and couldn’t find it. Somehow they heard I had it, called me and asked me to mail it to them. Imagine: a retired schoolteacher being called by the United States Senate and asked for one of their secret documents! The US Senate, through the Government Reform Committee, is trying to stop this type of government research.
The title page of a genuine US Senate Study, declassified on February 24, 1977, shows that George Merck, of the pharmaceutical company, Merck Sharp & Dohme (which now makes cures for diseases that at one time it created), reported in 1946 to the US Secretary of War that his researchers had managed “for the first time” to “isolate the disease agent in crystalline form”.3
They had produced a crystalline bacterial toxin extracted from the Brucella bacterium. The bacterial toxin could be removed in crystalline form and stored, transported and deployed without deteriorating. It could be delivered by other vectors such as insects, aerosol or the food chain (in nature it is delivered within the bacterium). But the factor that is working in the Brucella is the mycoplasma.
Brucella is a disease agent that doesn’t kill people; it disables them. But, according to Dr Donald MacArthur of the Pentagon, appearing before a congressional committee in 1969,(4) researchers found that if they had mycoplasma at a certain strength – actually, 10 to the 10th power – it would develop into AIDS, and the person would die from it within a reasonable period of time because it could bypass the natural human defenses. If the strength was 10 to 8, the person would manifest with chronic fatigue syndrome or fibromyalgia. If it was l0 to 7, they would present as wasting; they wouldn’t die and they wouldn’t be disabled, but they would not be very interested in life; they would waste away.
Most of us have never heard of the disease brucellosis because it largely disappeared when they began pasteurizing milk, which was the carrier. One salt shaker of the pure disease agent in a crystalline form could sicken the entire population of Canada. It is absolutely deadly, not so much in terms of killing the body but disabling it.
Because the crystalline disease agent goes into solution in the blood, ordinary blood and tissue tests will not reveal its presence. The mycoplasma will only crystallize at 8.1 pH, and the blood has a pH of 7.4 pH. So the doctor thinks your complaint is “all in your head”.
Crystalline Brucella and Multiple Sclerosis
In 1998 in Rochester, New York, I met a former military man, PFC Donald Bentley, who gave me a document and told me: “I was in the US Army, and I was trained in bacteriological warfare. We were handling a bomb filled with brucellosis, only it wasn’t brucellosis; it was a Brucella toxin in crystalline form. We were spraying it on the Chinese and North Koreans.”
He showed me his certificate listing his training in chemical, biological and radiological warfare. Then he showed me 16 pages of documents given to him by the US military when he was discharged from the service. They linked brucellosis with multiple sclerosis, and stated in one section: “Veterans with multiple sclerosis, a kind of creeping paralysis developing to a degree of 10% or more disability within two years after separation from active service, may be presumed to be service-connected for disability compensation. Compensation is payable to eligible veterans whose disabilities are due to service.” In other words: “If you become ill with multiple sclerosis, it is because you were handling this Brucella, and we will give you a pension. Don’t go raising any fuss about it.” In these documents, the government of the United States revealed evidence of the cause of multiple sclerosis, but they didn’t make it known to the public – or to your doctor.
In a 1949 report, Drs Kyger and Haden suggested “the possibility that multiple sclerosis might be a central nervous system manifestation of chronic brucellosis”. Testing approximately 113 MS patients, they found that almost 95% also tested positive for Brucella.(5) We have a document from a medical journal, which concludes that one out of 500 people who had brucellosis would develop what they call neurobrucellosis; in other words, brucellosis in the brain, where the Brucella settles in the lateral ventrides – where the disease multiple sclerosis is basically located.6
Contamination of Camp Detrick Lab Workers
A 1948 New England Journal of Medicine report titled “Acute Brucellosis Among Laboratory Workers” shows us how actively dangerous this agent is.7 The laboratory workers were from Camp Detrick, Frederick, Maryland, where they were developing biological weapons. Even though these workers had been vaccinated, wore rubberised suits and masks and worked through holes in the compartment, many of them came down with this awful disease because it is so absolutely and terrifyingly infectious.
The article was written by Lt Calderone Howell, Marine Corps Captain Edward Miller, Marine Corps, Lt Emily Kelly, United States Naval Reserve; and Captain Henry Bookman. They were all military personnel engaged in making the disease agent Brucella into a more effective biological weapon
III – COVERT TESTING OF MYCOPLASMA
Testing the Dispersal Methods
Documented evidence proves that the biological weapons they were developing were tested on the public in various communities without their knowledge or consent.
The government knew that crystalline Brucella would cause disease in humans. Now they needed to determine how it would spread and the best way to disperse it. They tested dispersal methods for Brucella suis and Brucella melitensis at Dugway Proving Ground, Utah, in June and September 1952. Probably, 100% of us now are infected with Brucella suis and Brucella melitensis.(8)
Another government document recommended the genesis of open-air vulnerability tests and covert research and development programs to be conducted by the Army and supported by the Central Intelligence Agency.
At that time, the Government of Canada was asked by the US Government to cooperate in testing weaponized Brucella, and Canada cooperated fully with the United States. The US Government wanted to determine whether mosquitoes would carry the disease and also if the air would carry it. A government report stated that “open-air testing of infectious biological agents is considered essential to an ultimate understanding of biological warfare potentialities because of the many unknown factors affecting the degradation of micro-organisms in the atmosphere”.9
Testing via Mosquito Vector in Punta Gorda, Florida
A report from The New England Journal of Medicine reveals that one of the first outbreaks of chronic fatigue syndrome was in Punta Gorda, Florida, back in 1957. (10) It was a strange coincidence that a week before these people came down with chronic fatigue syndrome, there was a huge influx of mosquitoes.
The National Institutes of Health claimed that the mosquitoes came from a forest fire 30 miles away. The truth is that those mosquitoes were infected in Canada by Dr. Guilford B. Reed at Queen’s University. They were bred in Belleville, Ontario, and taken down to Punta Gorda and released there.
Within a week, the first five cases ever of chronic fatigue syndrome were reported to the local clinic in Punta Gorda. The cases kept coming until finally, 450 people were ill with the disease.
Testing via Mosquito Vector in Ontario
The Government of Canada had established the Dominion Parasite Laboratory in Belleville, Ontario, where it raised 100 million mosquitoes a month. These were shipped to Queen’s University and certain other facilities to be infected with this crystalline disease agent The mosquitoes were then let loose in certain communities in the middle of the night, so that the researchers could determine how many people would become ill with chronic fatigue syndrome or fibromyalgia, which was the first disease to show.
One of the communities they tested it on was the St Lawrence Seaway valley, all the way from Kingston to Cornwall, in 1984. They let out hundreds of millions of infected mosquitoes. Over 700 people in the next four or five weeks developed myalgic encephalomyelitis or chronic fatigue syndrome.
IV – COVERT TESTING OF OTHER DISEASE AGENTS
Mad Cow Disease/Kuru/CJD in the Fore Tribe
Before and during World War II, at the infamous Camp 731 in Manchuria, the Japanese military contaminated prisoners of war with certain disease agents.
They also established a research camp in New Guinea in 1942. There they experimented upon the Fore Indian tribe and inoculated them with a minced-up version of the brains of diseased sheep containing the visna virus which causes “mad cow disease” or Creutzfeldt – Jakob disease.
About five or six years later, after the Japanese had been driven out, the poor people of the Fore tribe developed what they called kuru, which was their word for “wasting”, and they began to shake, lose their appetites and die. The autopsies revealed that their brains had literally turned to mush. They had contracted “mad cow disease” from the Japanese experiments.
When World War II ended, Dr. Ishii Shiro – the medical doctor who was commissioned as a General in the Japanese Army so he could take command of Japan’s biological warfare development, testing, and deployment – was captured. He was given the choice of a job with the United States Army or execution as a war criminal. Not surprisingly, Dr. Ishii Shiro chose to work with the US military to demonstrate how the Japanese had created mad cow disease in the Fore Indian tribe.
In 1957, when the disease was beginning to blossom in full among the Fore people, Dr. Carleton Gajdusek of the US National Institutes of Health headed to New Guinea to determine how the minced-up brains of the visna-infected sheep affected them. He spent a couple of years there, studying the Fore people, and wrote an extensive report. He won the Nobel Prize for “discovering” kuru disease in the Fore tribe.
Testing Carcinogens over Winnipeg, Manitoba
In 1953, the US Government asked the Canadian Government if it could test a chemical over the city of Winnipeg. It was a big city with 500,000 people, miles from anywhere. The American military sprayed this carcinogenic chemical in a 1,000%-attenuated form, which they said would be so watered down that nobody would get very sick; however, if people came to clinics with a sniffle, a sore throat or ringing in their ears, the researchers would be able to determine what percentage would have developed cancer if the chemical had been used at full strength.
We located evidence that the Americans had indeed tested this carcinogenic chemical – zinc cadmium sulphide – over Winnipeg in 1953. We wrote to the Government of Canada, explaining that we had solid evidence of the spraying and asking that we be informed as to how high up in the government the request for permission to spray had gone. We did not receive a reply.
Shortly after, the Pentagon held a press conference on May 14, 1997, where they admitted what they had done. Robert Russo, writing for the Toronto Star11 from Washington, DC, reported the Pentagon’s admission that in 1953 it had obtained permission from the Canadian Government to fly over the city of Winnipeg and spray out this chemical – which sifted down on kids going to school, housewives hanging out their laundry and people going to work. US Army planes and trucks released the chemical 36 times between July and August 1953. The Pentagon got its statistics, which indicated that if the chemical released had been full strength, approximately a third of the population of Winnipeg would have developed cancers over the next five years.
One professor, Dr Hugh Fudenberg, MD, twice nominated for the Nobel Prize, wrote a magazine article stating that the Pentagon came clean on this because two researchers in Sudbury, Ontario – Don Scott and his son, Bill Scott – had been revealing this to the public. However, the legwork was done by other researchers!
The US Army actually conducted a series of simulated germ warfare tests over Winnipeg. The Pentagon lied about the tests to the mayor, saying that they were testing a chemical fog over the city, which would protect Winnipeg in the event of a nuclear attack.
A report commissioned by US Congress, chaired by Dr. Rogene Henderson, lists 32 American towns and cities used as test sites as well.
V – BRUCELLA MYCOPLASMA AND DISEASE AIDS
The AIDS pathogen was created out of a Brucella bacterium mutated with a visna virus; then the toxin was removed as a DNA particle called a mycoplasma. They used the same mycoplasma to develop disabling diseases like MS, Crohn’s colitis, Lyme disease, etc.
In the previously mentioned US congressional document of a meeting held on June 9, 1969, (12) the Pentagon delivered a report to Congress about biological weapons. The Pentagon stated: “We are continuing to develop disabling weapons.” Dr MacArthur, who was in charge of the research, said: “We are developing a new lethal weapon, a synthetic biological agent that does not naturally exist, and for which no natural immunity could have been acquired.”
Think about it. If you have a deficiency of acquired immunity, you have an acquired immunity deficiency. Plain as that. AIDS.
In laboratories throughout the United States and in a certain number in Canada including at the University of Alberta, the US Government provided the leadership for the development of AIDS for the purpose of population control. After the scientists had perfected it, the government sent medical teams from the Centers for Disease Control-under the direction of Dr Donald A. Henderson, their investigator into the 1957 chronic fatigue epidemic in Punta Gorda – during 1969 to 1971 to Africa and some countries such as India, Nepal and Pakistan where they thought the population was becoming too large.13 They gave them all a free vaccination against smallpox; but five years after receiving this vaccination, 60% of those inoculated were suffering from AIDS. They tried to blame it on a monkey, which is nonsense.
A professor at the University of Arkansas made the claim that while studying the tissues of a dead chimpanzee she found traces of HIV. The chimpanzee that she had tested was born in the United States 23 years earlier. It had lived its entire life in a US military laboratory where it was used as an experimental animal in the development of these diseases. When it died, its body was shipped to a storage place where it was deep-frozen and stored in case they wanted to analyze it later. Then they decided that they didn’t have enough space for it, so they said, “Anybody wants this dead chimpanzee?” and this researcher from Arkansas said: “Yes. Send it down to the University of Arkansas. We are happy to get anything we can get.” They shipped it down and she found HIV in it. That virus was acquired by that chimpanzee in the laboratories where it was tested.14
Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis
Chronic fatigue syndrome is more accurately called myalgic encephalomyelitis. The chronic fatigue syndrome nomenclature was given by the US National Institutes of Health because it wanted to downgrade and belittle the disease.
An MRI scan of the brain of a teenage girl with chronic fatigue syndrome displayed a great many scars or punctate lesions in the left frontal lobe area where portions of the brain had literally dissolved and been replaced by scar tissue. This caused cognitive impairment, memory impairment, etc. And what was the cause of the scarring? The mycoplasma. So there is very concrete physical evidence of these tragic diseases, even though doctors continue to say they don’t know where it comes from or what they can do about it.
Many people with chronic fatigue syndrome, myalgic encephalo-myelitis, and fibromyalgia who apply to the Canada Pensions Plan Review Tribunal will be turned down because they cannot prove that they are ill. During 1999 I conducted several appeals to Canada Pensions and the Workers Compensation Board (WCB, now the Workplace Safety and Insurance Board) on behalf of people who have been turned down. I provided documented evidence of these illnesses, and these people were all granted their pensions on the basis of the evidence that I provided.
In March 1999, for example, I appealed to the WCB on behalf of a lady with fibromyalgia who had been denied her pension back in 1993. The vice-chairman of the board came to Sudbury to hear the appeal, and I showed him a number of documents which proved that this lady was physically ill with fibromyalgia. It was a disease that caused physical damage, and the disease agent was a mycoplasma. The guy listened for three hours, and then he said to me: “Mr. Scott, how is it I have never heard of any of this before? I said: “We brought a top authority in this area into Sudbury to speak on this subject and not a single solitary doctor came to that presentation.”
VI-TESTING FOR MYCOPLASMA IN YOUR BODY
Polymerase Chain Reaction Test
Information is not generally available about this agent because, first of all, the mycoplasma is such a minutely small disease agent. A hundred years ago, certain medical theoreticians conceived that there must be a form or disease agent smaller than bacteria and viruses. This pathogenic organism, the mycoplasma, is so minute that normal blood and tissue tests will not reveal its presence as the source of the disease.
Your doctor may diagnose you with Alzheimer’s disease, and he will say:
“Golly, we don’t know where Alzheimer’s comes from. All we know is that your brain begins to deteriorate, cells rupture, the myelin sheath around the nerves dissolves, and so on.” Or if you have chronic fatigue syndrome, the doctor will not be able to find any cause for your illness with ordinary blood and tissue tests.
This mycoplasma couldn’t be detected until about 30 years ago when the polymerase chain reaction (PCR) test was developed, in which a sample of your blood is examined and damaged particles are removed and subjected to a polymerase chain reaction. This causes the DNA in the particles to break down. The particles are then placed in a nutrient, which causes the DNA to grow back into its original form. If enough of the substance is produced, the form can be recognized, so it can be determined whether Brucella or another kind of agent is behind that particular mycoplasma.
If you or anybody in your family has myalgic encephalomyelitis, fibromyalgia, multiple sclerosis or Alzheimer’s, you can send a blood sample to Dr. Les Simpson in New Zealand for testing.
If you are ill with these diseases, your red blood cells will not be normal doughnut-shaped blood cells capable of being compressed and squeezed through the capillaries but will swell up like cherry-filled doughnuts which cannot be compressed. The blood cells become enlarged and distended because the only way the mycoplasma can exist is by uptaking pre-formed sterols from the host cell. One of the best sources of pre-formed sterols is cholesterol, and cholesterol is what gives your blood cells flexibility. If the cholesterol is taken out by the mycoplasma, the red blood cell swells up and doesn’t go through, and the person begins to feel all the aches and pains and all the damage it causes to the brain, the heart, the stomach, the feet, and the whole body because blood and oxygen are cut off.
And that is why people with fibromyalgia and chronic fatigue syndrome have such a terrible time. When the blood is cut off from the brain, punctate lesions appear because those parts of the brain die. The mycoplasma will get into portions of the heart muscle, especially the left ventricle, and those cells will die. Certain people have cells in the lateral ventricles of the brain that have a genetic predisposition to admit the mycoplasma, and this causes the lateral ventricles to deteriorate and die. This leads to multiple sclerosis, which will progress until these people are totally disabled; frequently, they die prematurely. The mycoplasma will get into the lower bowel, parts of which will die, thus causing colitis. All of these diseases are caused by the degenerating properties of the mycoplasma.
In early 2000, a gentleman in Sudbury phoned me and told me he had fibromyalgia. He applied for a pension and was turned down because his doctor said it was all in his head and there was no external evidence. I gave him the proper form and a vial, and he sent his blood to Dr. Simpson to be tested. He did this with his family doctor’s approval, and the results from Dr. Simpson showed that only 4% of his red blood cells were functioning normally and carrying the appropriate amount of oxygen to his poor body, whereas 83% were distended, enlarged and hardened, and wouldn’t go through the capillaries without an awful lot of pressure and trouble. This is the physical evidence of the damage that is done.
You can also ask your doctor to give you a 24-hour Holter ECG. You know, of course, that an electrocardiogram is a measure of your heartbeat and shows what is going on in the right ventricle, the left ventricle and so on. Tests show that 100% of patients with chronic fatigue syndrome and fibromyalgia have an irregular heartbeat. At various periods during the 24 hours, the heart, instead of working happily away going “bump-BUMP, bump-BUMP”, every now and again goes “buhbuhbuhbuhbubbuhbuhbuhbuh”. The T-wave (the waves are called P, Q, R, S, and T) is normally a peak, and then the wave levels off and starts with the P-wave again. In chronic fatigue and fibromyalgia patients, the T-wave flattens off or actually inverts. That means the blood in the left ventricle is not being squeezed up through the aorta and around through the body.
My client from Sudbury had this test done and, lo and behold, the results stated: “The shape of T and S-T suggests left ventricle strain pattern, although voltage and so on is normal.” The doctor had no clue as to why the T-wave was not working properly. I analyzed the report of this patient who had been turned down by Canada Pensions and sent it back to them. They wrote back, saying: “It looks like we may have made a mistake. We are going to give you a hearing and you can explain this to us in more detail.”
So it is not all in your imagination. There is actual physical damage to the heart. The left ventricle muscles do show scarring.
That is way many people are diagnosed with a heart condition when they first develop fibromyalgia, but it’s only one of several problems because the mycoplasma can do all kinds of damage.
Blood Volume Test
You can also ask your doctor for a blood volume test. Every human being requires a certain amount of blood per pound of body weight, and it has been observed that people with fibromyalgia, chronic fatigue syndrome, multiple sclerosis and other illnesses do not have the normal blood volume their body needs to function properly. Doctors aren’t normally aware of this.
This test measures the amount of blood in the human body by taking out 5 cc, putting a tracer in it and then putting it back into the body. One hour later, take out 5 cc again and look for the tracer. The thicker the blood and the lower the blood volume, the more tracer you will find.
The analysis of one of my clients stated: “This patient was referred for red cell mass study. The red cell volume is 16.9 ml per kg of body weight. The normal range is 25 to 35 ml per kg. This guy has 36% less blood in his body than the body needs to function.” And the doctor hadn’t even known the test existed.
If you lost 36% of your blood in an accident, do you think your doctor would tell you that you are alright and should just take up line dancing and get over it? They would rush you to the nearest hospital and start transfusing you with blood. These tragic people with these awful diseases are functioning with anywhere from 7% to 50% less blood than their body needs to function.
VII- UNDOING THE DAMAGE
The body undoes the damage itself. The scarring in the brain of people with chronic fatigue and fibromyalgia will be repaired. There is cellular repair going on all the time. But the mycoplasma has moved on to the next cell.
In the early stages of a disease, doxycydine may reverse that disease process. It is one of the tetracycline antibiotics, but it is not bactericidal; it is bacteriostatic – it stops the growth of the mycoplasma. And if the mycoplasma growth can be stopped for long enough, then the immune system takes over.
Doxycycline treatment is discussed in a paper by mycoplasma expert Professor Garth Nicholson, Ph.D., of the Institute for Molecular Medicine. Dr. Nicholson is involved in a US$8 million mycoplasma research program funded by the US military and headed by Dr. Charles Engel of the NIH. The program is studying Gulf War veterans, 450 of them because there is evidence to suggest that Gulf War syndrome is another illness (or set of illnesses) caused by mycoplasma.
1. “Pathogenic Mycoplasma”, US Patent No. 5,242,820, issued September 7, 1993. Dr Lo is listed as the Inventor” and the American Registry of Pathology, Washington, DC, is listed as the “Assignee”.
2. “Special Virus Cancer Program: Progress Report No. 8”, prepared by the National Cancer Institute, Viral Oncology, Etiology Area, July 1971, submitted to NIH Annual Report in May 1971 and updated July 1971.
3. US Senate, Ninety-fifth Congress, Hearings before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, Biological Testing Involving Human Subjects by the Department of Defense, 1977; released as US Army Activities in the US Biological Warfare Programs, Volumes One and Two, 24 February 1977.
4. Dr. Donald MacArthur, Pentagon, Department of Defense Appropriations for 1970, Hearings before Subcommittee of the Committee on Appropriations, House of Representatives, Ninety-First Congress, First Session, Monday, June 9, 1969, pp 105 – 144, esp. pp. 114, 129.
5. Kyger, E. R., and Russell L. Haden, “Brucellosis and Multiple Sclerosis”, The American Journal of Medical Sciences 1949:689-693.
6. Colmonero et al., “Complications Associated with Brucella melitensis Infection: A Study of 530 Cases”, Medicine 1996;75(4).
7. Howell, Miller, Kelly and Bookman, “Acute Brucellosis Among Laboratory Workers”, New England Journal of Medicine 1948;236:741.
8. “Special Virus Cancer Program: Progress Report No. 8”, ibid., table 4, p. 135.
9. US Senate, Hearings before the Subcommittee on Health and Scientific Research of the Committee on Human Resources, March 8 and May 23, 1977, ibid.
10. New England Journal of Medicine, August 22, 1957, p. 362.
11. Toronto Star, May 15, 1997.
12. Dr. Donald MacArthur, Pentagon, Department of Defense Appropriations for 1970, Hearings, Monday, June 9, 1969, ibid., p.129.
13. Henderson, Donald A., “Smallpox: Epitaph for a Killer”, National Geographic, December 1978, p. 804.
14. Blum, Deborah, The Monkey Wars, Oxford University Press, New York, 1994.
15. Nicholson, G. 1., “Doxycycline treatment and Desert Storm”, JAMA 1995;273:61 8-619.
– Horowitz, Leonard, Emerging Viruses: Aids and Ebola, Tetrahedron Publishing, USA, 1996.
– Johnson, Hillary, Osler’s Web, Crown Publishers, New York, 1996.
– Scott, Donald W., and William L. C. Scott, The Brucellosis Triangle, The Chelmsford Publishers (Box 133, Stat. B., Sudbury, Ontario P3E 4N5), Canada, 1998 (US$21.95 + $3 s&h in US).
– Scott, Donald W. and William 1. C. Scott, The Extremely Unfortunate Skull Valley Incident, The Chelmsford Publishers, Canada, 1996 (revised, extended edition available from mid-September 2001; US$16.00 pre-pub. Price + US$3 s&h in US).
– The Journal of Degenerative Diseases (Donald W. Scott, Editor), The Common Cause Medical Research Foundation (Box 133, Stat B., Sudbury, Ontario, P3E 4N5), Canada (quarterly journal; annual subscription: US$25.00 in USA, $30 foreign).
– Ms Jennie Burke, Australian Biologics, Level 6, 383 Pitt Street, Sydney NSW 2000, Australia tel +61 (0)2 9283 0807, fax +61 (0)2 9283 0910. Australian Biologics does tests for mycoplasma.
– Consumer Health Organization of Canada, 1220 Sheppard Avenue East #412, Toronto, Ontario, Canada M2K 255, tel +1 (416)490 0986, website.
– Professor Garth Nicholson, Ph.D., Institute for Molecular Medicine, 15162 Triton Lane, Huntington Beach, CA, 92649-1401, USA, tel +1(714) 903 2900.
– Dr. Les Simpson, Red Blood Cell Research Ltd, 31 Bath Street, Dunedin, 9001, New Zealand, tel +64 (0)3 471 8540, email [email protected] . (Note: Dr. Simpson directs his study to red cell shape analysis, not the mycoplasrna hypothesis.)
– The Mycoplasma Registry for Gulf War Illness, S. & 1. Dudley, 303 47th St, J-10 San Diego, CA 92102-5961, tel/fax +1(619) 266 1116, fax (619) 266 1116, email [email protected]
Image Courtesy: nexusilluminati.blogspot.com
About the Author:
Donald Scott, MA, MSc, is a retired high school teacher and university professor. He is also a veteran of WWII and was awarded the North Atlantic Star, the Burma Star with Clasp, the 1939 – 1945 Volunteer Service Medal and the Victory Medal. He is currently President of The Common Cause Medical Research Foundation, a not-for-profit organization devoted to research into neurosystemic degenerative diseases. He is also Adjunct Professor with the Institute for Molecular Medicine and he produces and edits the Journal of Degenerative Diseases. He has extensively researched neurosystemic degenerative diseases over the past five years and has authored many documents on the relationship between degenerative diseases and a pathogenic mycoplasma called Mycoplasma fermentans. His research is based upon solid government evidence.
Extracted from Nexus Magazine, Volume 8, Number 5 (August-September 2001)
PO Box 30, Mapleton Qld 4560 Australia. [email protected]
Telephone: +61 (0)7 5442 9280; Fax: +61 (0)7 5442 9381
From our web page at www.nexusmagazine.com
© by Donald W. Scott, MA, MSc © 2001
The Common Cause
Medical Research Foundation
190 Mountain Street, Suite 405
Sudbury, Ontario, Canada P3B 4G2
Tel/fax: +1 (705) 670 0180
Research & Reference Links:
I – THE MYCOPLASMA
A COMMON PATHOGENIC MYCOPLASMA
BIOWARFARE RESEARCH DOCUMENTED EVIDENCE
II – CREATION OF THE MYCOPLASMA
MYCOPLASMA PATENTA LABORATORY-CREATED PATHOGEN BY THE U.S. MILITARY
COMMITTEE ON GOVERNMENT REFORM
BIOLOGICAL WARFARE RESEARCH AGREEMENT
CRYSTALLINE BRUCELLOSIS AND MULTIPLE SCLEROSIS
CONTAMINATION OF CAMP DETRICK LAB WORKERS
III – COVERT TESTING OF THE MYCOPLASMA
TESTING BRUCELLOSIS UPON AN UNSUSPECTING PUBLIC
TESTING BRUCELLOSES VIA MOSQUITO VECTOR IN PUNTA GORDA
TESTING BRUCELLOSIS VIA MOSQUITO VECTOR IN ONTARIO
IV – OTHER SECRET GOVERNMENT TESTING
MAD COW DISEASE IN THE FORE INDIAN TRIBE
TESTING CARCINOGENS IN RUSSIA
TESTING CARCINOGENS IN WINNIPEG
V – BRUCELLOSIS MYCOPLASMA AND DISEASE
APPEALS TO CANADA PENSION
VI – TESTING FOR THE PRESENCE OF MYCOPLASMA IN YOUR BODY
THE POLYMERASE CHAIN REACTION TEST
THE BLOOD TEST
THE ECG TEST
BLOOD VOLUME TEST
UNDOING THE DAMAGE
GULF WAR RESEARCH
Mycoplasmas – Stealth Pathogens
Mycoplasmas are a specific and unique species of bacteria – the smallest free-living organism known on the planet. The primary differences between mycoplasmas and other bacteria are that bacteria have a solid cell-wall structure and they can grow in the simplest culture media. Mycoplasmas, however, do not have a cell wall, and like a tiny jellyfish with a pliable membrane, can take on many different shapes which make them difficult to identify, even under a high powered electron microscope. Mycoplasmas can also be very hard to culture in the laboratory and are often missed as pathogenic causes of diseases for this reason.
The accepted name was chosen because Mycoplasmas were observed to have a fungi-like structure (Mycology is the study of fungi – hence “Myco”) and it also had a flowing plasma-like structure without a cell wall – hence “plasma”. The first strains were isolated from cattle with arthritis and pleuro-pneumonia in 1898 at the Pasteur Institute. The first human strain was isolated in 1932 from an abscessed wound. The first connection between mycoplasmas and rheumatoid diseases was made in 1939 by Drs. Swift and Brown. Unfortunately, mycoplasmas didn’t become part of the medical school curriculum until the late 1950’s when one specific strain was identified and proven to be the cause of atypical pneumonia and named Mycoplasma pneumonia. The association between immunodeficiency and autoimmune disorders with mycoplasmas was first reported in the mid-1970s in patients with primary hypogammaglobulinemia (an autoimmune disease) and infection with four species of mycoplasma that had localized in joint tissue. Since that time, scientific testing methodologies have made critical technological progress and along with it, more mycoplasma species have been identified and recorded in animals, humans and even plants.
While Mycoplasma pneumonia is certainly not the only species causing disease in humans, it makes for a good example of how this stealth pathogen can move out of its typical environment and into other parts of the body and begin causing other diseases. While residing in the respiratory tract and lungs, Mycoplasma pneumonia remains an important cause of pneumonia and other airway disorders, such as tracheobronchitis, pharyngitis, and asthma. When this stealth pathogen hitches a ride to other parts of the body, it is associated with non-pulmonary manifestations, such as blood, skin, joints, central nervous system, liver, pancreas, and cardiovascular syndromes and disorders. Even as far back as 1983, doctors at Yale noted:
“Over the past 20 years, the annual number of reports on extrapulmonary symptoms during Mycoplasma (M.) pneumoniae disease has increased. Clinical and epidemiological data indicate that symptoms from the skin and mucous membranes, from the central nervous system, from the heart, and perhaps from other organs as well are not quite uncommon manifestations of M. pneumoniae disease.” (15)
This single stealth pathogen has been discovered in the urogenital tract of patients suffering from inflammatory pelvic disease, urethritis, and other urinary tract diseases (8) It has been discovered in the heart tissues and fluid of patients suffering from cardititis, pericarditis, tachycardia, hemolytic anemia, and other coronary heart diseases.(9, 10, 14) It has been found in the cerebrospinal fluid of patients with meningitis and encephalitis, seizures, ALS, Alzheimer’s and other central nervous system infections, diseases and disorders.(11-13) It has even been found regularly in the bone marrow of children with leukemia.(16- 18) It is amazing that one single tiny bacteria can be the cause of so many seemingly unrelated diseases in humans. But as with all mycoplasma species, the disease is directly related to where the mycoplasma resides in the body and which cells in the body it attaches to or invades.
Today, over 100 documented species of mycoplasmas have been recorded to cause various diseases in humans, animals, and plants. Mycoplasma pneumonia as well as at least 7 other mycoplasma species have now been linked as a direct cause or significant co-factor to many chronic diseases including, rheumatoid arthritis, Alzheimer’s, multiple sclerosis, fibromyalgia, chronic fatigue, diabetes, Crohn’s Disease, ALS, nongonoccal urethritis, asthma, lupus, infertility, AIDS and certain cancers and leukemia, just to name a few.(1-6)
In 1997, the National Center for Infectious Diseases, Centers for Disease Control and Prevention’s journal, Emerging Infectious Diseases, published the article, Mycoplasmas: Sophisticated, Reemerging, and Burdened by Their Notoriety, by Drs. Baseman and Tully who stated:
“Nonetheless, mycoplasmas by themselves can cause acute and chronic diseases at multiple sites with wide-ranging complications and have been implicated as cofactors in disease. Recently, mycoplasmas have been linked as a cofactor to AIDS pathogenesis and to malignant transformation, chromosomal aberrations, the Gulf War Syndrome, and other unexplained and complex illnesses, including chronic fatigue syndrome, Crohn’s disease, and various arthritides.”
Mycoplasmas, unlike viruses, can grow in tissue fluids (blood, joint, heart, chest and spinal fluids) and can grow inside any living tissue cell without killing the cells, as most normal bacteria and viruses will do. Mycoplasmas are frequently found in the oral and genito-urinary tracts of normal healthy people and are found to infect females four times more often than males, which just happens to be the same incidence rate in rheumatoid arthritis, fibromyalgia, Chronic Fatigue and other related disorders. (7)
Mycoplasmas are parasitic in nature and can attach to specific cells without killing the cells and thus their infection process and progress can go undetected. In some people, the attachment of mycoplasmas to the host cell acts like a living thorn; a persistent foreign substance, causing the host’s immune defense mechanism to wage war. This allergic type of inflammation often results in heated, swollen, and painful inflamed tissues, like those found in rheumatoid diseases, fibromyalgia and many other autoimmune disorders like lupus and MS, Crohn’s and others. In such cases, the immune system begins attacking itself and/or seemingly healthy cells. Some species of mycoplasmas also have the unique ability to completely evade the immune system. Once they attach to a host cell in the body, their unique plasma and protein coating can then mimic the cell wall of the host cell and the immune system cannot differentiate the mycoplasma from the body’s own host cell.
Mycoplasmas are parasitic in nature because they rely on the nutrients found in host cells including cholesterol, amino acids, fatty acids, and even DNA. They especially thrive in cholesterol-rich and arginine-rich environments. Mycoplasmas can generally be found in the mucous membrane in the respiratory tract. They need cholesterol for membrane function and growth, and there is an abundance of cholesterol in the bronchial tubes of the respiratory tract. Once attached to a host cell, they then begin competing for nutrients inside the host cells. As nutrients are depleted, then these host cells can begin to malfunction, or even change normal functioning of the cell, causing a chain reaction with other cells (especially within the immune and endocrine systems). Mycoplasmas can even cause RNA and DNA mutation of the host cells and have been linked to certain cancers for this reason. Mycoplasmas can also invade and live inside host cells which evade the immune system, especially white blood cells. Once inside a white blood cell, mycoplasmas can travel throughout the body and even cross the blood/brain barrier, and into the central nervous system and spinal fluid.
Baseman, Joel, et.al., Mycoplasmas: Sophisticated, Reemerging, and Burdened by Their Notoriety, CDC, Journal of Infectious Diseases, Vol 3, No.1, Feb 1997
S-C. Mycoplasmas and AIDS. In: Maniloff J, McElhaney RN, Finch LR, Baseman JB, editors. Mycoplasmas: molecular biology and pathogenesis. Washington (DC): American Society for Microbiology, 1992:525-45.
Nicolson G, Nicolson NL. Diagnosis and treatment of mycoplasmal infections in Gulf War illness-CFIDS patients. Intl J Occup Med Immunol Toxicol 1996;5:69-78.
Wear DJ, et.al. Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation. Proc Natl Acad Sci USA 1995;92:10197-201.
Ekbom A, Daszak P, Kraaz W, Wakefield AJ. Crohn’s disease after in-utero measles virus exposure. Lancet 1996;348:516-7.
Taylor-Robinson D. Mycoplasmas in rheumatoid arthritis and other human arthritides. J Clin Pathol 1996;49:781-2.
Dr.Harold Clark, The Intercessor, June 1993, The Road Back Foundation, Delaware OH.
Goulet M, et.al., Isolation of Mycoplasma pneumoniae from the human urogenital tract. J Clin Microbiol 1995;33:2823-5
Daxbock F, et.al., Severe hemolytic anemia and excessive leukocytosis masking mycoplasma pneumonia. Ann Hematol. 2001 Mar;80(3):180-2.
Higuchi ML, et.al., Detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured atherosclerotic plaques. Braz J Med Biol Res. 2000 Sep;33(9):1023-6.
Socan M, Neurological symptoms in patients whose cerebrospinal fluid is culture- and/or polymerase chain reaction-positive for Mycoplasma pneumoniae. Clin Infect Dis. 2001 Jan 15;32(2):E31-5.
Bencina D, et.al., Intrathecal synthesis of specific antibodies in patients with invasion of the central nervous system by Mycoplasma pneumoniae. Eur J Clin Microbiol Infect Dis. 2000 Jul;19(7):521-30
Smith R, et.al., Neurologic manifestations of Mycoplasma pneumoniae infections: diverse spectrum of diseases. A report of six cases and review of the literature. Clin Pediatr (Phila). 2000 Apr;39(4):195-201.
Umemoto M, Advanced atrioventricular block associated with atrial tachycardia caused by Mycoplasma pneumoniae infection. Acta Paediatr Jpn. 1995 Aug;37(4):518-20.
Lind K. Manifestations and complications of Mycoplasma pneumoniae disease: a review.Yale J Biol Med. 1983 Sep-Dec;56(5-6):461-8.
Alexander FE. Is Mycoplasma Pneumonia associated with childhood acute lymphoblastic leukemia? Cancer Causes Control. 1997 Sep;8(5):803-11.
Hall JE, Mycoplasma pneumonia in acute childhood leukemia. Pediatr Pulmonol. 1985 Nov-Dec;1(6):333-6.
Murphy WH, Gullis C, Dabich L, Heyn R, Zarafonetis CJD. Isolation of Mycoplasma from leukemic and nonleukemia patients. J Nat Cancer Inst 1970;45:243-51.
How Mycoplasmas Interact in the Body
To understand how mycoplasmas can cause widespread disease, we must first look at the species’ unique properties and interactions with host cells. Unlike viruses and bacteria, mycoplasmas are the smallest free-living and self-duplicating microorganisms, as they don’t require living cells to replicate their DNA and growth.
Mycoplasmas are able to hide inside the cells of the host (patient) or to attach to the outside of host cells. Whether they live inside or outside the host cell, they depend on host cells for nutrients such as cholesterol, amino acids, etc. They compete with the host cells for these nutrients which can interfere with host cell function without killing the host cell.
A mycoplasma has very little DNA of its own but is capable of using DNA from a host cell. When a mycoplasma takes over the DNA of the host cell, anything can happen – including causing that cell to malfunction in many different ways and/or die, or can cause DNA mutation of the host cell. Mycoplasmas attach to host cells with a tiny arm coated in protein which attaches to the protein coating of host cells. For this reason, antibiotics like tetracycline, which are classified as “protein synthesis inhibitors” are often used against mycoplasma infections. While these antibiotics may block this protein attachment and very slowly starve it from the nutrients it needs from host cells to thrive and replicate, it still takes a healthy immune system to actually kill the mycoplasma for good.
Mycoplasmas are highly adaptable to changing environments and can move anywhere in the body, attaching to or invading virtually any type of cell in the body. The mycoplasma adhesion proteins are very similar to human proteins. Once adhered to the host cell, the mycoplasma can completely mimic or copy the protein cell of the host cell. This can cause the immune system to begin attacking the body’s own cells; an event that happens in all autoimmune diseases.
Certain Mycoplasma species can either activate or suppress host immune systems, and they may use these activities to evade host immune responses. Mycoplasmas can turn on the chain reaction called an immune system response. This includes the stimulation of pro-inflammatory cytokines (chemical messengers of the immune system) which is generally found in most autoimmune and inflammatory diseases and disorders. Mycoplasma can also attach to or invade immune system cells, like the very phagocytes (natural killer cells) that are supposed to kill them. Inside these phagocytes, they can be carried to new locations of inflammation or disease – hidden away like a spy who has infiltrated the defending army. When a mycoplasma attaches to a host cell, it generates and releases hydrogen peroxide and superoxide radicals which cause oxidative stress and damage to the surrounding tissues.
The Main Human Mycoplasma Pathogens
Pathogen / Implicated Disease (1-6)
|Mycoplasma genitalium||Arthritis, chronic nongonococcal urethritis, chronic pelvic inflammatory disease, other urogenital infections and diseases, infertility, AIDS/HIV|
|Mycoplasma fermentans||Arthritis, Gulf War Syndrome, Fibromyalgia, Chronic Fatigue Syndrome, Lupus, AIDS/HIV, autoimmune diseases, ALS, psoriasis and Scleroderma, Crohn’s and IBS, cancer, endocrine disorders, Multiple Sclerosis, diabetes|
|Mycoplasma salivarium||Arthritis, TMJ disorders, Eye and ear disorders and infections, gingivitis, periodontal diseases including even cavities.|
|Mycoplasma hominis and Ureaplasma urealyticum||Pelvic inflammatory disease, infertility, non-gonococcal urethritis, vaginitis, cervicitis, amnionitis, pyelonephritis, post-partum septicemia, neonatal pneumonia, neonatal conjunctivitis, Reiter’s syndrome, peritonitis, wound infections (C-section), low birth weight infants, and premature rupture of membranes.|
|Mycoplasma pneumonia||Pneumonia, asthma, upper and lower respiratory diseases, heart diseases, leukemia, Steven-Johnson syndrome, polyarthritis or septic arthritis, CNS disorders and diseases, urinary tract infections, Crohn’s and Irritable Bowel Syndrome, Guillain-Barr syndrome, polyradiculitis, encephalitis, and septic meningitis, autoimmune diseases.|
|Mycoplasma incognitus and
|AIDS/HIV, urogenital infections and diseases, Autoimmune disorders and diseases|
|Mycoplasma pirum||Urogenital infections and diseases, AIDS/HIV|
|Mycoplasma faucium, M. lipophilum and M. buccale||Diseases of the gingival crevices and respiratory tract|
Krause DC, Taylor-Robinson D. Mycoplasmas which infect humans. In: Maniloff J, McElhaney RN, Finch LR, Baseman JB, editors. Mycoplasmas: molecular biology and pathogenesis. Washington (DC): American Society for Microbiology, 1992:417-44.
Murray HW, Masur H, Senterfit LB, Roberts RB. The protean manifestations of Mycoplasma pneumoniae infection in adults. Am J Med 1975;58:229-42.
Baseman, Joel, et.al., Mycoplasmas: Sophisticated, Reemerging and Burdened by Their Notoriety. CDC, Journal of Infectious Diseases, Vol 3, No.1, Feb 1997
Blanchard, A., et.al., AIDS-associated mycoplasmas. Ann.Rev.Microbiol. 1994; 48:687-712.
Hawkins, et.al., Association of mycoplasma and human immunodeficiency virus infection: detection of amplified mycoplasma fermentans DNA in blood. J.Infec.Dis. 1992: 165:581-585
Hussain AI, et.al., Mycoplasma penetrans and other mycoplasmas in the urine of human immunodeficiency virus-positive children. J Clin Microbiol. 1999 May;37(5):1518-23.
•Horowitz, Leonard, Emerging Viruses: Aids and Ebola, Tetrahedron Publishing, USA, 1996.
• Johnson, Hillary, Osler’s Web, Crown Publishers, New York, 1996.
• Scott, Donald W. and William L. C. Scott, The Brucellosis Triangle, The Chelmsford Publishers (Box 133, Stat. B., Sudbury, Ontario P3E 4N5), Canada, 1998 (US$21.95 + $3 s&h in US).
• Scott, Donald W. and William 1. C. Scott, The Extremely Unfortunate Skull Valley Incident, The Chelmsford Publishers, Canada, 1996 (revised, extended edition available from mid-September 2001; US$16.00 pre-pub. Price + US$3 s&h in US).
•The journal of Degenerative Diseases (Donald W. Scott, Editor), The Common Cause Medical Research Foundation (Box 133, Stat B., Sudbury, Ontario, P3E 4N5), Canada (quarterly journal; annual subscription: US$25.00 in USA, $30 foreign).
• Ms Jennie Burke, Australian Biologics, Level 6, 383 Pitt Street, Sydney NSW 2000, Australia tel +61 (0)2 9283 0807, fax +61 (0)2 9283 0910. Australian Biologics does tests for mycoplasma.
• Consumer Health Organization of Canada, 1220 Sheppard Avenue East #412, Toronto, Ontario, Canada M2K 255, tel +1 (416)490 0986, website www.consumerhealth.org/.
• Professor Garth Nicholson, PhD, Institute for Molecular Medicine, 15162 Triton Lane, Huntington Beach, CA, 92649-1401, USA, tel +1(714) 903 2900.
• Dr Les Simpson, Red Blood Cell Research Ltd, 31 Bath Street, Dunedin, 9001, New Zealand, tel +64 (0)3 471 8540, email [email protected] . (Note: Dr Simpson directs his study to red cell shape analysis, not the mycoplasrna hypothesis.)
• The Mycoplasma Registry for Gulf War Illness, S. & 1. Dudley, 303 47th St, J-10 San Diego, CA 92102-5961, tel/fax +1(619) 266 1116, fax (619) 266 1116, email [email protected].
About the Author
Donald Scott, MA, MSc, is a retired high school teacher and university professor. He is also a veteran of WWII and was awarded the North Atlantic Star, the Burma Star with Clasp, the 1939—1945 Volunteer Service Medal and the Victory Medal. He is currently President of The Common Cause Medical Research Foundation, a not-for-profit organisation devoted to research into neurosystemic degenerative diseases. He is also Adjunct Professor with the Institute for Molecular Medicine and he produces and edits the journal of Degenerative Diseases. He has extensively researched neurosystemic degenerative diseases over the past five years and has authored many documents on the relationship between degenerative diseases and a pathogenic mycoplasma called Mycoplasma fermentans. His research is based upon solid government evidence.
You may contact Donald Scott at: 190 Mountain St., Ste. 405, Sudbury, Ontario, Canada P3B 4G2. 705-670-0180.
Note: Dr. David Webster at Sudbury General Hospital, a wonderful person, with whom I have had conversations about these awful diseases can tell your doctor about the Blood Volume test.